Ninerafaxstat Well-Tolerated and Safe for Nonobstructive Hypertrophic Cardiomyopathy

Phase 2 trial shows early signs that the investigational drug could relieve symptoms and improve exercise capacity in HCM patients with no other evidence-based treatment options available

Related Keywords

Massachusetts ,United States ,Burlington ,Martins Maron , ,Hypertrophic Cardiomyopathy Center At Lahey Hospital ,Journal Of The American College Cardiology ,American College Of Cardiology Annual Scientific Session ,Imbria Pharmaceuticals ,American College ,Annual Scientific ,Hypertrophic Cardiomyopathy Center ,Lahey Hospital ,Medical Center ,Kansas City Cardiomyopathy Questionnaires ,